Breaking Biotech News: Regeneron to Acquire Troubled 23andMe for $256 Million Amid Bankruptcy
Published: May 19, 2025 In a significant move within the biotechnology sector, pharmaceutical giant Regeneron Pharmaceuticals announced today, May 19th, its successful bid to acquire the well-known genetic testing company 23andMe Holding Co. The deal, valued at $256 million, will see Regeneron take ownership of 23andMe through a bankruptcy auction. This acquisition comes after a